DREAMM12
A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function
Arms / Cohorts
Experimental Arm:Patients with Normal / Mild Impaired Renal Function
Accepting patients
Experimental Arm:Patients with Severe Renal Impairment
Accepting patients
Experimental Arm:Patients with End Stage Renal Disease, Not on Dialysis
Accepting patients
Experimental Arm:Patients with End Stage Renal Disease, On Dialysis
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.